Investor insights
Sectors invested in
Contract Manufacturing1
Monoclonal Antibody Therapeutics1
Contract Research1
Antibody Drug Conjugates1
Association1
Biotechnology1
Non Profit1
Manufacturing1
Funding rounds participated in
$59M sweet spot round size
Most of their 1 investments are in rounds between $59M and $59M
Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
Life Science
Health Care
Date founded
2017
Investments made
M
MabPlex International Co., Ltd. raised $59M on January 17, 2019
Investors: Apollomics, ANTAGENE, 深圳裕策生物科技有限公司, 澳斯康生物制药Thousand Oaks Biopharmaceuticals, Shenzhen Capital Group Co., Ltd and Apic Bio, Inc.
Funding rounds raised
Total raised
$42M
from 3 investors over 3 rounds
A
Apic Bio, Inc. raised $42M on January 7, 2019
Investors: Morningside Venture Capital 晨兴资本 and ALS Investment Fund
A
Apic Bio, Inc. raised $1M on August 23, 2017
Investors: Alpha-1 Foundation